Jesper Sundell

6PUBLICATIONS
12CO-AUTHORS
Stochastic analysis and modellingRegenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Epidemiological methodsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2026
Learning Covariate Relations in Disease Progression Models Using Symbolic Neural Networks.

Jesper Sundell, Ylva Wahlquist, Maria C Kjellsson

|Nov 05, 2024
Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT interval.

Jesper Sundell, Dinko Rekic, Johanna Melin

|Mar 06, 2024
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses.

Joanna Parkinson, Jesper Sundell, Dinko Rekić

|Sep 07, 2022
Effects of Enzyme Induction and Polymorphism on the Pharmacokinetics of Isoniazid and Rifampin in Tuberculosis/HIV Patients.

Jesper Sundell, Emile Bienvenu, Sofia Birgersson

|Aug 02, 2021
Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIV.

Jesper Sundell, Emile Bienvenu, Angela Äbelö

|Nov 13, 2019
Population Pharmacokinetics and Pharmacogenetics of Ethambutol in Adult Patients Coinfected with Tuberculosis and HIV.

Jesper Sundell, Emile Bienvenu, Sofia Birgersson

Pageof 1